Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 255Carcinoma, Renal Cell 94Urinary Bladder Neoplasms 74Carcinoma, Transitional Cell 43Breast Neoplasms 41Colorectal Neoplasms 37Ovarian Neoplasms 36Melanoma 32Kidney Neoplasms 32Carcinoma, Non-Small-Cell Lung 31Neoplasms 28Neoplasm Metastasis 26Sarcoma 22Non-Muscle Invasive Bladder Neoplasms 22Endometrial Neoplasms 22Uterine Cervical Neoplasms 21Lung Neoplasms 21Stomach Neoplasms 19Triple Negative Breast Neoplasms 18Pancreatic Neoplasms 18Carcinoma, Hepatocellular 18Wilms Tumor 17Squamous Cell Carcinoma of Head and Neck 17Adenocarcinoma 17Head and Neck Neoplasms 14Esophageal Neoplasms 14Metastatic Castration-resistant Prostate Cancer 13Rhabdomyosarcoma 12Osteosarcoma 12Neuroblastoma 12

Interventions

Counseling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Castration-Resistant Prostate Cancer (CRPC) × Genitourinary × 30 days × Clear all
NCT07240857 2026-05-22

A Clinical Study Evaluating the Safety and Efficacy of Local Injection of ACT#001 Chimeric Antigen Receptor T Cells in the Treatment of Castration-Resistant Prostate Cancer

Zhejiang University

Phase EARLY_PHASE1 Enrolling by invitation
18 enrolled
Genitourinary

Castration-Resistant Prostate Cancer (CRPC)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡